UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Mercury Insurance
MCY
$6.07B
| $1.23M | ﹤0.01% |
27,675
-28,600
| -51% | -$1.41M |
|
|
BWIN
1852
Baldwin Insurance Group
BWIN
$2.86B
| $1.22M | ﹤0.01% |
50,642
| – | – |
|
|
RWT
1853
Redwood Trust
RWT
$594M
| $1.22M | ﹤0.01% |
158,225
+2,275
| +1% | +$20.9K |
|
|
RDUS
1854
DELISTED
Radius Recycling
RDUS
| $1.22M | ﹤0.01% |
37,039
+1,372
| +4% | +$58.5K |
|
1855
CryoPort
CYRX
$762M
| $1.22M | ﹤0.01% |
39,252
-5,321
| -12% | -$142K |
|
1856
ADT
ADT
$5.58B
| $1.21M | ﹤0.01% |
197,296
+14,978
| +8% | +$104K |
|
1857
The Greenbrier Companies
GBX
$1.46B
| $1.21M | ﹤0.01% |
33,587
-5,083
| -13% | -$212K |
|
|
EVOP
1858
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.21M | ﹤0.01% |
51,326
| – | – |
|
1859
Aclaris Therapeutics
ACRS
$869M
| $1.2M | ﹤0.01% |
86,267
+36,921
| +75% | +$517K |
|
|
VIVO
1860
DELISTED
Meridian Bioscience Inc
VIVO
| $1.2M | ﹤0.01% |
39,502
| – | – |
|
1861
First Busey Corp
BUSE
$2.56B
| $1.2M | ﹤0.01% |
52,530
| – | – |
|
1862
Tilray
TLRY
$622M
| $1.2M | ﹤0.01% |
38,452
+8,573
| +29% | +$405K |
|
|
AGNT
1863
AGNT Inc
AGNT
$734M
| $1.19M | ﹤0.01% |
101,416
+4,659
| +5% | +$67.4K |
|
1864
C3.ai
AI
$1.59B
| $1.19M | ﹤0.01% |
65,224
-51,264
| -44% | -$942K |
|
1865
Madrigal Pharmaceuticals
MDGL
$11.8B
| $1.19M | ﹤0.01% |
16,634
+4,204
| +34% | +$309K |
|
|
DCT
1866
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $1.18M | ﹤0.01% |
79,614
+5,721
| +8% | +$100K |
|
|
EFC
1867
Ellington Financial
EFC
$1.71B
| $1.18M | ﹤0.01% |
80,562
-757
| -0.9% | -$11.9K |
|
1868
Preferred Bank
PFBC
$1.25B
| $1.18M | ﹤0.01% |
17,370
| – | – |
|
1869
Fulgent Genetics
FLGT
$527M
| $1.17M | ﹤0.01% |
21,469
-4,416
| -17% | -$243K |
|
1870
Comstock Resources
CRK
$3.94B
| $1.17M | ﹤0.01% |
96,848
+33,186
| +52% | +$549K |
|
1871
Hillman Solutions
HLMN
$1.79B
| $1.17M | ﹤0.01% |
135,113
+35,833
| +36% | +$394K |
|
1872
Scholastic
SCHL
$792M
| $1.17M | ﹤0.01% |
32,433
| – | – |
|
|
MODV
1873
DELISTED
ModivCare
MODV
| $1.16M | ﹤0.01% |
13,779
-481
| -3% | -$48.6K |
|
1874
Buckle
BKE
$2.37B
| $1.16M | ﹤0.01% |
41,987
+1,723
| +4% | +$54K |
|
1875
Clean Energy Fuels
CLNE
$346M
| $1.16M | ﹤0.01% |
259,423
+39,349
| +18% | +$228K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.